Leqembi ® Iqlik™, a subcutaneous (SC) formulation of lecanemab, is now available as a maintenance dosing regimen for the treatment of Alzheimer disease in patients with mild cognitive impairment or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback